iSpecimen expands provider network to advance infectious disease research

iSpecimen announced that the Company has added several new infectious disease specimen providers to its global supply network. These new collaborations will enable iSpecimen to connect researchers with additional providers of essential human tissue and biofluids required for infectious disease research. Researchers will have access to clinically collected samples, banked tissues and custom collections of biospecimens, including viral positives and health control swabs, saliva, serum and plasma. “The iSpecimen Marketplace’s large network provides access to high volumes of samples with associated data that supports infectious disease research efforts as well as the unique needs of diagnostic companies,” said Tracy Curley, iSpecimen’s CEO. “Our global network, combined with our custom project capabilities, provides researchers with diverse samples – including those from hard-to-reach populations – to advance diagnostic test and treatment development, ultimately leading to improved patient outcomes.”